Clinical and Radiographic Evaluation of Intrabony Periodontal Defects Treated with Hyaluronic Acid or Enamel Matrix Proteins: A 6-Month Prospective Study
2024

Comparing Treatments for Periodontal Defects

Sample size: 60 publication Evidence: moderate

Author Information

Author(s): Vela Octavia-Carolina, Boariu Marius, Rusu Darian, Iorio-Siciliano Vincenzo, Sculean Anton, Stratul Stefan-Ioan

Primary Institution: Victor Babes University of Medicine and Pharmacy

Hypothesis

Does cross-linked hyaluronic acid provide similar regenerative effects as enamel matrix proteins in treating periodontal intrabony defects?

Conclusion

Both treatments, EMD and xHyA, produced similar statistically significant clinical and radiographical improvements after six months when compared with baseline.

Supporting Evidence

  • 54 patients were available for statistical analysis after 6 months.
  • Mean CAL gain was statistically significant in both groups.
  • Mean PPD reduction was statistically significant in both groups.
  • Both treatments showed similar improvements in clinical parameters.

Takeaway

Doctors tested two treatments for gum problems and found that both worked well after six months.

Methodology

Sixty patients with one intrabony defect each were randomly assigned to receive either EMD or xHyA, with clinical parameters measured at baseline and after 6 months.

Limitations

The study was limited to one research center and lacked histological analysis.

Participant Demographics

60 nonsmoking, systemically healthy patients aged 30 to 50 years, with a balanced gender distribution.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3290/j.ohpd.b5569745

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication